|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
EP0088046B1
(de)
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
EP0143949B1
(en)
|
1983-11-01 |
1988-10-12 |
TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION |
Pharmaceutical composition containing urokinase
|
|
US4740461A
(en)
|
1983-12-27 |
1988-04-26 |
Genetics Institute, Inc. |
Vectors and methods for transformation of eucaryotic cells
|
|
US4959455A
(en)
|
1986-07-14 |
1990-09-25 |
Genetics Institute, Inc. |
Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
|
|
EP0281604B1
(en)
|
1986-09-02 |
1993-03-31 |
Enzon Labs Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4912040A
(en)
|
1986-11-14 |
1990-03-27 |
Genetics Institute, Inc. |
Eucaryotic expression system
|
|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US4968607A
(en)
|
1987-11-25 |
1990-11-06 |
Immunex Corporation |
Interleukin-1 receptors
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5683888A
(en)
|
1989-07-22 |
1997-11-04 |
University Of Wales College Of Medicine |
Modified bioluminescent proteins and their use
|
|
US5292658A
(en)
|
1989-12-29 |
1994-03-08 |
University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center |
Cloning and expressions of Renilla luciferase
|
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
WO1991018982A1
(en)
|
1990-06-05 |
1991-12-12 |
Immunex Corporation |
Type ii interleukin-1 receptors
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DK0575319T3
(da)
|
1991-03-11 |
2000-07-10 |
Univ Georgia Res Found |
Kloning og ekspression af Renilla-luciferase
|
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
JPH06508035A
(ja)
|
1991-06-14 |
1994-09-14 |
ディーエヌエックス コーポレーション |
トランスジェニックブタにおけるヒトヘモグロビンの生産
|
|
EP0593592B1
(en)
|
1991-07-08 |
1998-03-25 |
The University Of Massachusetts At Amherst |
Thermotropic liquid crystal segmented block copolymer
|
|
US5470582A
(en)
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
|
ES2301158T3
(es)
|
1992-07-24 |
2008-06-16 |
Amgen Fremont Inc. |
Produccion de anticuerpos xenogenicos.
|
|
CA2169298A1
(en)
|
1993-09-10 |
1995-03-16 |
Martin Chalfie |
Uses of green fluorescent protein
|
|
WO1995021191A1
(en)
|
1994-02-04 |
1995-08-10 |
William Ward |
Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein
|
|
US5777079A
(en)
|
1994-11-10 |
1998-07-07 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
|
US5804387A
(en)
|
1996-02-01 |
1998-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
FACS-optimized mutants of the green fluorescent protein (GFP)
|
|
US5876995A
(en)
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
|
US5925558A
(en)
|
1996-07-16 |
1999-07-20 |
The Regents Of The University Of California |
Assays for protein kinases using fluorescent protein substrates
|
|
DE69740096D1
(de)
|
1996-08-08 |
2011-02-17 |
Amylin Pharmaceuticals Inc |
Pharmazeutische Zusammensetzung mit einem Exendin-4-Peptid
|
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
|
AU5518798A
(en)
|
1996-12-03 |
1998-06-29 |
Trustees Of Boston University |
Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
|
|
US7091183B1
(en)
|
1996-12-03 |
2006-08-15 |
Boston Medical Center Corporation |
Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
ATE290205T1
(de)
|
1996-12-12 |
2005-03-15 |
Prolume Ltd |
Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
|
|
JP4798814B2
(ja)
|
1997-01-07 |
2011-10-19 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
食物摂取低減用のエキセンジンおよびそのアゴニストの使用
|
|
CA2196496A1
(en)
|
1997-01-31 |
1998-07-31 |
Stephen William Watson Michnick |
Protein fragment complementation assay for the detection of protein-protein interactions
|
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
ES2293688T5
(es)
|
1997-08-08 |
2011-05-04 |
Amylin Pharmaceuticals, Inc. |
Nuevos compuestos análogos de la exendina.
|
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
|
US7223725B1
(en)
|
1997-11-14 |
2007-05-29 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
CA2309356C
(en)
|
1997-11-14 |
2010-09-21 |
Amylin Pharmaceuticals, Inc. |
Novel exendin agonist compounds
|
|
US7220721B1
(en)
|
1997-11-14 |
2007-05-22 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist peptides
|
|
NZ504258A
(en)
|
1997-11-14 |
2002-12-20 |
Amylin Pharmaceuticals Inc |
Exendin 3 and 4 agonist compounds for the treatment of diabetes
|
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
WO1999040788A1
(en)
|
1998-02-13 |
1999-08-19 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and glp-1
|
|
AU765703B2
(en)
|
1998-03-27 |
2003-09-25 |
Bruce J. Bryan |
Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
|
|
DE69926007T2
(de)
|
1998-10-07 |
2005-12-29 |
Medical College Of Georgia Research Institute, Inc. |
Glukose-abhängiges, insulinotropisches peptid für die verwendung als osteotropes hormon
|
|
PL208751B1
(pl)
|
1998-12-07 |
2011-06-30 |
Sod Conseils Rech Applic |
Związki stanowiące analogi GLP-1, kompozycje zawierające takie związki oraz zastosowanie takich związków
|
|
CA2358107C
(en)
|
1998-12-22 |
2011-08-23 |
Eli Lilly And Company |
Shelf-stable formulation of glucagon-like peptide-1
|
|
JP2002538084A
(ja)
|
1999-01-14 |
2002-11-12 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
グルカゴンを抑制する方法
|
|
US20030087820A1
(en)
|
1999-01-14 |
2003-05-08 |
Young Andrew A. |
Novel exendin agonist formulations and methods of administration thereof
|
|
RU2242244C2
(ru)
|
1999-01-14 |
2004-12-20 |
Амилин Фармасьютикалз, Инк. |
Новые композиции агонистов эксендина и способы их введения
|
|
US20050272652A1
(en)
|
1999-03-29 |
2005-12-08 |
Gault Victor A |
Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
|
|
ATE272650T1
(de)
|
1999-03-29 |
2004-08-15 |
Uutech Ltd |
Analoge des magensaft inhibierenden peptides und ihre verwendung für die behandlung von diabetes
|
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
AU1190101A
(en)
|
1999-09-27 |
2001-04-30 |
Regents Of The University Of California, The |
Engineering antibodies that bind irreversibly
|
|
WO2001051078A1
(en)
|
2000-01-10 |
2001-07-19 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
|
|
ATE264870T1
(de)
|
2000-01-27 |
2004-05-15 |
Lilly Co Eli |
Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen
|
|
WO2001087341A1
(en)
|
2000-05-16 |
2001-11-22 |
Sanwa Kagaku Kenkyusho Co.,Ltd. |
Agents for preventing or ameliorating insulin resistance and/or obesity
|
|
ES2464532T3
(es)
|
2001-04-19 |
2014-06-03 |
The Scripps Research Institute |
Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
|
|
US20050159379A1
(en)
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc |
RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)
|
|
JP4566459B2
(ja)
|
2001-06-07 |
2010-10-20 |
株式会社日立製作所 |
表示装置
|
|
WO2003055914A2
(en)
|
2001-12-21 |
2003-07-10 |
7Tm Pharma A/S |
Modified receptors for the discovery of therapeutic ligands
|
|
AU2003208945B2
(en)
|
2002-02-20 |
2008-05-01 |
Emisphere Technologies, Inc |
Method for administering GLP-1 molecules
|
|
JPWO2003097031A1
(ja)
|
2002-05-22 |
2005-09-15 |
株式会社三和化学研究所 |
メチリデンヒドラジド化合物を有効成分とする、肥満の予防又は改善剤
|
|
AU2003248676A1
(en)
|
2002-06-15 |
2003-12-31 |
Enteromed, Inc. |
Treatment of non-alcoholic fatty liver disease
|
|
JP2006213598A
(ja)
|
2003-03-19 |
2006-08-17 |
Sanwa Kagaku Kenkyusho Co Ltd |
ピラゾロピリミジン化合物及びその用途
|
|
ES2371072T3
(es)
|
2003-06-12 |
2011-12-27 |
Eli Lilly And Company |
Proteínas de fusión análogas de glp-1.
|
|
WO2005021022A2
(en)
|
2003-09-01 |
2005-03-10 |
Novo Nordisk A/S |
Stable formulations of peptides
|
|
KR20140011431A
(ko)
|
2004-02-11 |
2014-01-28 |
아밀린 파마슈티칼스, 엘엘씨. |
선택가능한 특성을 갖는 하이브리드 폴리펩티드
|
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
|
US7991890B2
(en)
|
2004-09-30 |
2011-08-02 |
Microsoft Corporation |
Game console communication with a device
|
|
NZ554386A
(en)
|
2004-10-25 |
2009-12-24 |
Cytos Biotechnology Ag |
Gastric inhibtory polypeptide (GIP) antigen arrays with VLPs and uses thereof
|
|
JP2008525452A
(ja)
|
2004-12-22 |
2008-07-17 |
イーライ リリー アンド カンパニー |
Ｇｌｐ−１類似体融合蛋白質製剤
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
|
CA2597649A1
(en)
|
2005-02-11 |
2006-08-17 |
Amylin Pharmaceuticals, Inc. |
Gip analog and hybrid polypeptides with selectable properties
|
|
EP1882044A1
(en)
|
2005-05-11 |
2008-01-30 |
sanofi-aventis |
Use of a gip promoter polymorphism
|
|
CN101180081B
(zh)
|
2005-05-25 |
2015-08-26 |
诺沃-诺迪斯克有限公司 |
稳定的多肽制剂
|
|
US20090170762A1
(en)
|
2005-09-08 |
2009-07-02 |
Uutech Limited |
Treatment of Diabetes Related Obesity
|
|
AU2007227202B2
(en)
|
2006-03-21 |
2013-08-22 |
Amylin Pharmaceuticals, Llc |
Peptide-peptidase inhibitor conjugates and methods of using same
|
|
EP2007804B1
(en)
|
2006-04-20 |
2014-06-18 |
Amgen, Inc |
Glp-1 compounds
|
|
AU2007240315A1
(en)
|
2006-04-20 |
2007-11-01 |
Amgen Inc. |
GLP-1 compound/glucagon antibody compositions
|
|
WO2008006113A2
(en)
|
2006-07-07 |
2008-01-10 |
The Texas A & M University System |
Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis
|
|
EP2068910A2
(en)
|
2006-08-04 |
2009-06-17 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and exendin agonists and glp-1 receptor agonists for altering lipoprotein particle size and subclass composition
|
|
US8497240B2
(en)
|
2006-08-17 |
2013-07-30 |
Amylin Pharmaceuticals, Llc |
DPP-IV resistant GIP hybrid polypeptides with selectable properties
|
|
JP5399244B2
(ja)
|
2006-08-17 |
2014-01-29 |
アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー |
選択可能な特性を持つｄｐｐ−ｉｖ耐性ｇｉｐハイブリッドポリペプチド
|
|
US20090098130A1
(en)
|
2007-01-05 |
2009-04-16 |
Bradshaw Curt W |
Glucagon-like protein-1 receptor (glp-1r) agonist compounds
|
|
NZ578948A
(en)
|
2007-02-15 |
2012-03-30 |
Univ Indiana Res & Tech Corp |
Glucagon/glp-1 receptor co-agonists
|
|
US8598314B2
(en)
|
2007-09-27 |
2013-12-03 |
Amylin Pharmaceuticals, Llc |
Peptide-peptidase-inhibitor conjugates and methods of making and using same
|
|
US20090144162A1
(en)
|
2007-11-29 |
2009-06-04 |
Neil Milne |
Transaction Security Method and Apparatus
|
|
GB0814068D0
(en)
|
2008-08-01 |
2008-09-10 |
Univ Ulster |
Active immunisation against GIP
|
|
ES2574835T3
(es)
|
2008-08-07 |
2016-06-22 |
Ipsen Pharma S.A.S. |
Análogos del polipéptido insulinotrópico dependiente de glucosa
|
|
KR20130133103A
(ko)
|
2008-08-07 |
2013-12-05 |
입센 파마 에스.에이.에스 |
Ｎ-말단이 변형된 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드(ｇｉｐ)의 유사체
|
|
CA2732949C
(en)
|
2008-08-07 |
2016-12-20 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide
|
|
CA2733005C
(en)
|
2008-08-07 |
2016-09-27 |
Ipsen Pharma S.A.S. |
Truncated analogues of glucose-dependent insulinotropic polypeptide
|
|
WO2010016936A1
(en)
|
2008-08-07 |
2010-02-11 |
Ipsen Pharma S.A.S. |
Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
|
|
WO2011014680A2
(en)
|
2009-07-31 |
2011-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gastric inhibitory peptide variants and their uses
|
|
KR20120123443A
(ko)
|
2010-01-27 |
2012-11-08 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
대사 장애 및 비만 치료용 글루카곤 길항제-ｇｉｐ 항진제 콘쥬게이트
|
|
US9023986B2
(en)
|
2010-10-25 |
2015-05-05 |
Hoffmann-La Roche Inc. |
Glucose-dependent insulinotropic peptide analogs
|
|
NZ612297A
(en)
|
2010-12-22 |
2015-10-30 |
Univ Indiana Res & Tech Corp |
Glucagon analogs exhibiting gip receptor activity
|
|
US20130344524A1
(en)
|
2011-03-08 |
2013-12-26 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Analysis method
|
|
KR102002783B1
(ko)
|
2011-06-10 |
2019-07-24 |
베이징 한미 파마슈티컬 컴퍼니 리미티드 |
포도당 의존성 인슐리노트로핀 폴리펩타이드 유사물질, 이의 약학적 조성물 및 응용
|
|
EP3539982B1
(en)
|
2011-12-23 |
2025-02-19 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
EP2851429B1
(en)
|
2012-05-18 |
2019-07-24 |
Adda Biotech Inc. |
Protein and protein conjugate for diabetes treatment, and applications thereof
|
|
MX2015002985A
(es)
|
2012-09-07 |
2015-06-22 |
Sanofi Sa |
Proteinas de fusion para el tratamiento de un sindrome metabolico.
|
|
WO2014100913A1
(en)
|
2012-12-24 |
2014-07-03 |
Beijing Anxinhuaide Biotech. Co., Ltd |
Improving the half life of a therapeutic polypeptide by fusing with a trimeric scaffold protein via a spacer
|
|
CN104371019B
(zh)
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
WO2015022420A1
(en)
|
2013-08-16 |
2015-02-19 |
Medimmune Limited |
Gip and glp-1 receptor dual-agonists for the treatment of diabetes
|
|
US20160297883A1
(en)
*
|
2013-12-04 |
2016-10-13 |
Innovative Targeting Solutions, Inc. |
G-protein coupled receptor agonists and methods
|
|
EP3079722B1
(en)
|
2013-12-13 |
2021-03-24 |
Novo Nordisk Health Care AG |
Method for thioether conjugation of proteins
|
|
ES2846099T3
(es)
|
2013-12-17 |
2021-07-28 |
Mhs Care Innovation Llc |
Composiciones y métodos para tratar la acumulación de tejidos grasos
|
|
ES2719584T3
(es)
|
2014-04-11 |
2019-07-11 |
Medimmune Llc |
Compuestos conjugados que comprenden anticuerpos modificados por ingeniería genética con cisteína
|
|
JP2017525656A
(ja)
|
2014-06-04 |
2017-09-07 |
ノヴォ ノルディスク アー／エス |
医療用のｇｌｐ−１／グルカゴン受容体コアゴニスト
|
|
JP2017531620A
(ja)
|
2014-09-12 |
2017-10-26 |
ジェネンテック， インコーポレイテッド |
システイン操作抗体及びコンジュゲート
|
|
US10097078B2
(en)
|
2014-10-21 |
2018-10-09 |
Toshiba International Corporation |
Multi-mode energy router
|
|
KR101825048B1
(ko)
*
|
2014-12-31 |
2018-02-05 |
주식회사 제넥신 |
GLP 및 면역글로불린 하이브리드 Fc 융합 폴리펩타이드 및 이의 용도
|
|
TWI783244B
(zh)
|
2015-06-22 |
2022-11-11 |
美商美國禮來大藥廠 |
升糖素及glp-1共激動劑化合物
|
|
TWI622596B
(zh)
|
2015-10-26 |
2018-05-01 |
美國禮來大藥廠 |
升糖素受體促效劑
|
|
CN117106085A
(zh)
|
2015-12-23 |
2023-11-24 |
美国安进公司 |
使用gipr结合蛋白与glp-1激动剂的组合来治疗或改善代谢病症的方法
|
|
EP4480537A3
(en)
|
2017-01-17 |
2025-03-12 |
Amgen Inc. |
Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)
|
|
US20180237095A1
(en)
|
2017-02-23 |
2018-08-23 |
Motive Power Industry Co., Ltd. |
Two-wheel suspension mechanism
|
|
CA3062194A1
(en)
|
2017-06-20 |
2018-12-27 |
Amgen Inc. |
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
|
|
JP7250706B2
(ja)
|
2017-06-21 |
2023-04-03 |
アムジエン・インコーポレーテツド |
胃抑制ペプチド受容体（ｇｉｐｒ）に対するアンタゴニスト結合タンパク質／ｇｌｐ－１受容体アゴニスト融合タンパク質を使用した代謝障害の治療又は寛解方法
|
|
MA68842B1
(fr)
|
2017-08-04 |
2025-01-31 |
Amgen Inc. |
Procédé de conjugaison de cys-mabs
|